41 results
Page 2 of 3
424B3
2g9i7n2
9 Apr 20
Prospectus supplement
9:30am
S-4/A
c0bnci
13 Mar 20
Registration of securities issued in business combination transactions (amended)
5:28pm
S-4
kuswav9vq5cwgh9
4 Feb 20
Registration of securities issued in business combination transactions
6:26am
8-K
EX-2.1
8b05 xuu72
21 Jan 20
Ritter Pharmaceuticals, Inc. and Qualigen, Inc. Announce Merger Agreement
9:20am
8-K
EX-2.2
0yk pa0pryu
21 Jan 20
Ritter Pharmaceuticals, Inc. and Qualigen, Inc. Announce Merger Agreement
9:20am
425
EX-2.2
l36w0gcezyn4e2154q63
21 Jan 20
Business combination disclosure
9:19am
425
EX-2.1
ee78 vsxi8d
21 Jan 20
Business combination disclosure
9:19am
8-K
EX-10.1
096kpk ftzr
6 Nov 19
Entry into a Material Definitive Agreement
9:56pm
8-K
EX-10.1
s49rlfqk kfyf9f7
2 Jul 18
Ritter Pharmaceuticals Announces Appointment of Andrew J. Ritter as Chief Executive Officer
6:01am